Literature DB >> 26095885

Effects of blood-flow-restricted resistance training on muscle function in a 74-year-old male with sporadic inclusion body myositis: a case report.

A N Jørgensen1,2, P Aagaard3, J L Nielsen3, U Frandsen3, L P Diederichsen4,5.   

Abstract

Sporadic inclusion body myositis (sIBM) is a systemic disease that is characterized by substantial skeletal muscle weakness and muscle inflammation, leading to impaired physical function. The objective was to investigate the effect of low-load resistance exercise with concurrent partial blood flow restriction to the working muscles (blood-flow-restricted (BFR) training) in a patient with sIBM. The training consisted of 12 weeks of lower extremity BFR training with low training loads (~25-RM). The patient was tested for mechanical muscle function and functional capacity before and after 6 and 12 weeks of training. Maximal horizontal gait speed increased by 19%, which was accompanied by 38-92% improvements in mechanical muscle function (maximal isometric strength, rate of force development and muscle power). In conclusion, BFR training was well tolerated by the patient with sIBM and led to substantial improvements in mechanical muscle function and gait speed.
© 2015 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blood-flow-restricted training; functional capacity; inflammatory myopathy; muscle power; muscle strength; rate of force development

Mesh:

Year:  2015        PMID: 26095885     DOI: 10.1111/cpf.12259

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  8 in total

1.  Immunohistochemical and ultrastructural analysis of sporadic inclusion body myositis: a case series.

Authors:  Katarzyna Haczkiewicz; Agata Sebastian; Aleksandra Piotrowska; Maria Misterska-Skóra; Agnieszka Hałoń; Marta Skoczyńska; Maciej Sebastian; Piotr Wiland; Piotr Dzięgiel; Marzenna Podhorska-Okołów
Journal:  Rheumatol Int       Date:  2018-12-08       Impact factor: 2.631

2.  Feasibility and safety of 4 weeks of blood flow-restricted exercise in an individual with tetraplegia and known autonomic dysreflexia: a case report.

Authors:  Søren Krogh; Anette B Jønsson; Jørgen Vibjerg; Kaare Severinsen; Per Aagaard; Helge Kasch
Journal:  Spinal Cord Ser Cases       Date:  2020-09-03

3.  Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.

Authors:  Jerry R Mendell; Zarife Sahenk; Samiah Al-Zaidy; Louise R Rodino-Klapac; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Natalie Miller; Mehmet Yalvac; Igor Dvorchik; Melissa Moore-Clingenpeel; Kevin M Flanigan; Kathleen Church; Kim Shontz; Choumpree Curry; Sarah Lewis; Markus McColly; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

4.  Clinical use of blood flow restriction in people with neurologic conditions: a cross-sectional survey.

Authors:  Mark M Mañago; Kyle Kimbrell; Emily R Hager; Hannah Dwight; Johnny Owens; Michael Bade
Journal:  J Phys Ther Sci       Date:  2022-04-08

Review 5.  Exercise in Myositis.

Authors:  Helene Alexanderson
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-11-23

6.  Exercise with blood flow restriction: an effective alternative for the non-pharmaceutical treatment for muscle wasting.

Authors:  Miguel S Conceição; Carlos Ugrinowitsch
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02-27       Impact factor: 12.910

7.  The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise training.

Authors:  Kasper Yde Jensen; Mikkel Jacobsen; Henrik Daa Schrøder; Per Aagaard; Jakob Lindberg Nielsen; Anders Nørkær Jørgensen; Eleanor Boyle; Rune Dueholm Bech; Sofie Rosmark; Louise Pyndt Diederichsen; Ulrik Frandsen
Journal:  Arthritis Res Ther       Date:  2019-12-18       Impact factor: 5.156

8.  Efficacy of low-load blood flow restricted resistance EXercise in patients with Knee osteoarthritis scheduled for total knee replacement (EXKnee): protocol for a multicentre randomised controlled trial.

Authors:  Stian Langgård Jørgensen; Marie Bagger Bohn; Per Aagaard; Inger Mechlenburg
Journal:  BMJ Open       Date:  2020-10-01       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.